These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 170678)

  • 1. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.
    Flier JS; Kahn CR; Roth J; Bar RS
    Science; 1975 Oct; 190(4209):63-5. PubMed ID: 170678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor.
    Jarrett DB; Roth J; Kahn CR; Flier JS
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4115-9. PubMed ID: 1069300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus caused by insulin-receptor blockade and impaired sensitivity to insulin.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Kromann H
    N Engl J Med; 1981 Apr; 304(18):1085-8. PubMed ID: 7010176
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies to the insulin receptor and insulin-resistant diabetes.
    Van Obberghen E; Grunfeld C; Harrison LC; Karlsson A; Muggeo M; Kahn CR
    Horm Res; 1982; 16(5):280-8. PubMed ID: 6757094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anti-insulin receptor autoantibodies on the metabolism of human adipocytes.
    Kasuga M; Akanuma Y; Tsushima T; Iwamoto Y; Kosaka K; Kibata M; Kawanishi K
    Diabetes; 1978 Sep; 27(9):938-45. PubMed ID: 689305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial insulin-resistant diabetes secondary to an affinity defect of the insulin receptor.
    Rüdiger HW; Dreyer M; Kühnau J; Bartelheimer H
    Hum Genet; 1983; 64(4):407-11. PubMed ID: 6352462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man.
    Roth J; Kahn CR; Lesniak MA; Gorden P; De Meyts P; Megyesi K; Neville DM; Gavin JR; Soll AH; Freychet P; Goldfine ID; Bar RS; Archer JA
    Recent Prog Horm Res; 1975; 31():95-139. PubMed ID: 744
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased insulin binding to cultured cells from a patient with the Rabson-Mendenhall syndrome: dichotomy between studies with cultured lymphocytes and cultured fibroblasts.
    Taylor SI; Underhill LH; Hedo JA; Roth J; Rios MS; Blizzard RM
    J Clin Endocrinol Metab; 1983 Apr; 56(4):856-61. PubMed ID: 6339538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.
    Kahn CR; Flier JS; Bar RS; Archer JA; Gorden P; Martin MM; Roth J
    N Engl J Med; 1976 Apr; 294(14):739-45. PubMed ID: 176581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.
    Flier JS; Kahn CR; Jarrett DB; Roth J
    J Clin Invest; 1977 Oct; 60(4):784-94. PubMed ID: 893677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of the insulin receptor defect in a patient with extreme insulin resistance.
    Taylor SI; Marcus-Samuels B; Ryan-Young J; Leventhal S; Elders MJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1130-5. PubMed ID: 3009519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemia.
    Flier JS; Bar RS; Muggeo M; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1978 Nov; 47(5):985-95. PubMed ID: 263346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of insulin receptor binding to monocytes and erythrocytes in newly diagnosed type II diabetes mellitus.
    Prager R; Schernthaner G
    Horm Metab Res; 1982 Nov; 14(11):561-3. PubMed ID: 6759349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.
    Olefsky JM; Reaven GM
    Am J Med; 1976 Jan; 60(1):89-95. PubMed ID: 175653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance.
    Grigorescu F; Flier JS; Kahn CR
    Diabetes; 1986 Feb; 35(2):127-38. PubMed ID: 3510919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The insulin receptors of the blood cells and their study in disease states in man (author's transl)].
    Thomopoulos P
    Ann Endocrinol (Paris); 1981; 42(4-5):381-9. PubMed ID: 7340695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.
    Bar RS; Levis WR; Rechler MM; Harrison LC; Siebert C; Podskalny J; Roth J; Muggeo M
    N Engl J Med; 1978 May; 298(21):1164-71. PubMed ID: 651946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of the insulin-receptor interaction in lipoatropic diabetes.
    Wachslicht-Rodbard H; Muggeo M; Kahn CR; Saviolakis GA; Harrison LC; Flier JS
    J Clin Endocrinol Metab; 1981 Mar; 52(3):416-25. PubMed ID: 7007407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance.
    Taylor SI; Leventhal S
    J Clin Invest; 1983 Jun; 71(6):1676-85. PubMed ID: 6345588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Mediated Insulin Resistance: When Insulin and Insulin Receptor Act as Autoantigens in Humans.
    Liminet C; Vouillarmet J; Chikh K; Disse E
    Can J Diabetes; 2016 Oct; 40(5):462-465. PubMed ID: 27062110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.